Efficacy and Safety Study of Sofosbuvir Containing Regimens in Subjects With Chronic Hepatitis C Virus Genotype 3 Infection
Phase of Trial: Phase III
Latest Information Update: 20 Jan 2017
At a glance
- Drugs Sofosbuvir (Primary) ; Daclatasvir; Ledipasvir/sofosbuvir
- Indications Hepatitis C
- Focus Adverse reactions; Therapeutic Use
- 15 Jan 2017 Planned End Date changed from 1 Dec 2016 to 1 Dec 2018.
- 15 Jan 2017 Planned primary completion date changed from 1 Sep 2016 to 1 Sep 2018.
- 20 Oct 2015 New trial record